Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: mark3b ENSDARG00000026630

.

Description

MAP/microtubule affinity-regulating kinase 3b [Source:ZFIN;Acc:ZDB-GENE-060929-80]

Gene Synonyms

si:dkeyp-50f7.6, zgc:153725

Location

Chromosome 20: 43,792,866-43,917,689 reverse strand.

GRCz11:CM002904.2

About this gene

This gene has 3 transcripts (splice variants), 206 orthologues and 7 paralogues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSDART00000026213.11	mark3b-201	4411	754aa	ENSDARP00000008926.9	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A2CEF7	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSDART00000153134.2	mark3b-203	640	214aa	ENSDARP00000127106.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	U3JA41	5' and 3' truncations in transcript evidence prevent annotation of the start and the end of the CDS.CDS 5' and 3' incomplete,
ENSDART00000149897.2	mark3b-202	1263	No protein	-	An alternatively spliced transcript believed to contain intronic sequence relative to other, coding, transcripts of the same gene.Retained intron	-	-

.

Summary

.

.